Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PfizerfiledCriticalPfizer
Priority to UY27129ApriorityCriticalpatent/UY27129A1/en
Publication of UY27129A1publicationCriticalpatent/UY27129A1/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
Se refiere a L-lactato de sertralina, composiciones que lo contienen y procedimientos para su preparación.It refers to sertraline L-lactate, compositions containing it and procedures for its preparation.
UY27129A2002-01-212002-01-21
L-SERTRALINE LACTATE, SOME OTHER DERIVED SALTS PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PREPARATION PROCEDURES
UY27129A1
(en)
Compound 4-cyclobutyl-n - ((2s, 5r) -5-hydroxy-2-adamantyl) -2-morpholin-4-ylpyridine-5-carboxamide, inhibitor of the enzyme 11betahsd1; pharmaceutical composition comprising it; and its use in a method of prophylactic or therapeutic treatment of a warm-blooded animal.
USE OF COMPOUNDS DERIVED FROM REPLACED HETEROCICLES; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS AND OTHER ACTIVE AGENTS; AND ITS USE TO TREAT DIABETES, ATEROSCLEROTIC DISEASE OF ARTERIES BETWEEN OTHER DISEASES.